Prospective Evaluations of Infectious Complication in Lung Transplant Recipients

Launched by UNIVERSITY OF PITTSBURGH · Sep 13, 2005

Keywords

ClinConnect Summary

This clinical trial is looking at infections in people who have received lung transplants, particularly focusing on two types of infections: viral infections and one caused by a bacteria called Chlamydia pneumoniae. The goal is to understand how common these infections are and how they can affect the health of lung transplant recipients, especially in relation to a condition known as bronchiolitis obliterans, which can cause inflammation and scarring in the lungs.

To be eligible for this study, participants need to be patients who have had a lung transplant or are scheduled to receive one at the University of Pittsburgh Medical Center and are doing well after their transplant. The study is open to all individuals aged 65 and older. If you join the study, you can expect to be monitored for any infections and their outcomes over time. Your participation is voluntary, and it's important to be willing to take part in the research for it to be successful.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who have undergone lung transplantation or will undergo a lung transplant at the University of Pittsburgh Medical Center and are alive following transplant period will be eligible for the study.
• Exclusion Criteria:
• • Subjects not willing to participate in the research study.